BrightGene Bio-Medical Technology Co., Ltd. (SHSE: 688166)
Health Care · Pharmaceuticals · CN
CN¥33.53
-6.37% today · -39.8% 1Y
BrightGene Bio-Medical Technology Co., Ltd. (SHSE: 688166) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.18B.
Over the last twelve months the share price has lost 39.8%, trading between 28.74 and 72.88.
Tweenvest scores BrightGene Bio-Medical Technology Co., Ltd. across four factors: quality 63/100, value 36/100, growth 40/100, dividend 18/100. Its strongest factor is quality.
688166 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.18B
- Revenue (TTM)
- $200.84M
- P/E
- 144.59
- EPS
- 0.23
- Dividend yield
- 0.05%
- Beta (5Y)
- 0.19
- 52-week high
- CN¥72.88
- 52-week low
- CN¥28.74
- Avg volume (3M)
- —
- Shares outstanding
- 435.23M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bausch Health Companies Inc.NYSE: BHC | $2.26B | $5.98 | -1.08% |
| ApicHope Pharmaceutical Group Co., Ltd.SZSE: 300723 | $2.24B | CN¥33.42 | +0.45% |
| Haw Par Corporation LimitedSGX: H02 | $2.21B | S$12.77 | +0.55% |
| Pharvaris N.V.NasdaqGS: PHVS | $2.18B | $30.86 | -0.77% |
| Tonghua Golden-Horse Pharmaceutical Industry Co,LtdSZSE: 000766 | $2.16B | CN¥14.97 | -1.25% |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.15B | CN¥22.88 | +1.24% |
| Dermapharm Holding SEXTRA: DMP | $2.13B | €38.30 | -0.26% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.12B | HK$4.74 | -1.76% |
Figures last refreshed Oct 11, 2026.